Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial to Evaluate Early High Dose Therapy and Autologous Bone Marrow Transplantation as Part of Planned Initial Therapy for Poor Risk Intermediate/High Grade NHL

NCT00003578 is registered in ClinicalTrials.gov with Lymphoma Trials Office as lead sponsor.

NCT NCT00003578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial to Evaluate Early High Dose Therapy and Autologous Bone Marrow Transplantation as Part of Planned Initial Therapy for Poor Risk Intermediate/High Grade NHL
Lead sponsor
Lymphoma Trials Office
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 1993
Completion date
Not reported
Enrollment
500 (estimated)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma